Speaker Profile

M.D., Ph.D., Co-founder and CEO, BioNTech AG

Ugur key focus is translating scientific ideas into innovations that help individual patients, an interest that was originally prompted by his experiences as a trained physician. Ugur has received prestigious awards from the German Hemato-Oncology Association, the German Association for Immunology, the German Ministry of Education and Research, and the American Society of Clinical Oncology. Ugur is a co-founder of Ganymed Pharmaceuticals, a co-founder and chair of the translational research institute TRON, and a co-founder of the CI3- Rhein-Main Cluster for Individualized Immune Intervention.

Session Abstract – PMWC 2018 Silicon Valley

Session Synopsis: Cancer vaccines – a growing area in immunotherapy – boost the body’s natural immune system to fight cancer. Not only have these approaches shown to destroy cancer cells and thus stop a tumor from growing and spreading, there also is the promise to prevent cancer from coming back through the immune memory function. This session will dive into the safety and feasibility of creating tailored cancer vaccines that are personalized to an individual’s tumor.

Get Exclusive Access to the Top PMWC Talks

To receive the most comprehensive news and updates from the field of precision medicine, subscribe to the newsletter here.

Bonus for suscribing, you will get the access code for the top 3 talk videos from January's Precision Medicine World Conference.

You have successfully subscribed, you can access the talks here.